Not exact matches
MDSCs are immune cells originating
from bone marrow stem cells that possess strong immunosuppressive abilities and are known to play a role in
tumor formation and metastasis.
To better understand the
formation of metastases in pancreatic cancer, Christine Iacobuzio - Donahue, M.D., Ph.D., professor of pathology at Memorial Sloan Kettering Cancer Center, collected
tumor samples
from eight patients with the most common form of pancreatic cancer (pancreatic ductal adenocarcinoma) immediately after their deaths.
Using a fluorescent protein to detect Rgs16 expression, the investigators found that this gene is induced by pancreatic
tumor formation starting
from its earliest manifestation as ductal neoplasm all the way to advanced solid
tumor in a spatially and temporally coincidental manner.
Efforts aimed at finding better drug regimens would therefore greatly benefit
from a mouse model with an intrinsic marker that can indicate different stages of pancreatic
tumor formation leading to cancer and reflect the effects exerted by novel drug candidates.
Joining forces with dermatologists and oncologists
from the University Hospital in Zurich and backed by the University Research Priority Program «Translational Cancer Research,» Sommer's team was able to demonstrate that, in melanoma cells, the epigenetic factor EZH2 controls genes that govern
tumor growth as well as genes that are important for the
formation of metastases.
We subjected 474 mutant alleles curated
from 5,338
tumors to pooled in vivo
tumor formation assays and gene expression profiling.
In recent years, a substantial body of evidence
from clinical epidemiology and mouse models has revealed that the immune system presents a significant barrier to
tumor formation and progression.
Nevertheless, there has always been the nagging question: Does
tumor hypermethylation at the p16 locus cause or result
from cancer
formation?
We report that
tumor cells without mitochondrial DNA (mtDNA) show delayed
tumor growth, and that
tumor formation is associated with acquisition of mtDNA
from host cells.
The central focus of my future work is to elucidate the mechanisms by which tumorigenesis results in the conversion of TGFβ
from a suppressor of
tumor formation to a promoter of
tumor growth, invasion, and metastasis.
One such study, published in Biomedicine and Pharmacology in 2017, proposes that saponins
from asparagus might be a helpful component in preventing secondary
tumor formation.
Research shows that anthocyanin may work as an antioxidant to reduce cancer cells
from spreading as well as inhibit the
formation of
tumors.